Vitamin D Mass Spectrometry for Separate D2 and D3 Quantification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for measuring non-metabolized vitamin D in clinical settings are limited, as existing immunologically-based assays cannot separately resolve 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3, making it difficult to determine the source of nutritional deficiencies.
Innovation Solution
The development of methods using tandem mass spectrometry for quantitative measurement of non-metabolized vitamin D, involving derivatization with Cookson-type reagents like 4-phenyl-1,2,4-triazoline-3,5-dione (PTAD) followed by ionization and fragmentation to detect specific ions associated with vitamin D2 and vitamin D3, allowing for their separate quantification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If immunologically-based assays are used to measure vitamin D, then measurement simplicity is maintained, but the ability to separately resolve 25OHD2 and 25OHD3 is lost
Solution Approach 1:
The assay is segmented into two distinct measurement pathways: one for detecting 25OHD2 and another for detecting 25OHD3. This is achieved by using two different antibodies with different specificities - one antibody specific for 25OHD2 and another antibody specific for 25OHD3. Each antibody-capture bead complex selectively binds its target metabolite, allowing separate quantification of each form of vitamin D in the same sample.
2Measurement precision
If mass spectrometry with derivatization is used to separately detect vitamin D2 and D3, then measurement precision is improved, but device complexity and procedural difficulty increase
Solution Approach 1:
Magnetic beads coated with specific antibodies serve as intermediaries between the vitamin D metabolites and the detection system. These capture beads selectively bind 25OHD2 or 25OHD3 from the sample, concentrating the analytes and enabling their detection by mass spectrometry without requiring complex derivatization procedures. The beads act as a bridge that simplifies the overall measurement process while maintaining high precision.
3Measurement precision
If derivatization with Cookson-type reagents is performed before mass spectrometry, then detection sensitivity is improved, but measurement time and procedural complexity increase
Solution Approach 1:
The antibody-coated magnetic beads perform preliminary selective capture and concentration of 25OHD2 and 25OHD3 from the sample before mass spectrometry analysis. This preliminary enrichment step reduces the required detection sensitivity threshold and minimizes the need for time-consuming derivatization procedures, as the analytes are already concentrated and purified in the bead-bound complex prior to MS analysis.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables accurate and separate detection and quantification of vitamin D2 and vitamin D3 in samples, providing valuable insights into nutritional status and disease diagnosis, with a lower limit of quantitation as low as <2 ng/mL, improving the diagnosis and management of vitamin D-related disorders.
Implementation Method 1
The vitamin D is derivatized with a Cookson-type reagent, such as 4-phenyl-1,2,4-triazoline-3,5-dione (PTAD)
Implementation Method 2
subjecting the derivatized vitamin D to an ionization source under conditions suitable to generate one or more ions
Implementation Method 3
fragmenting the ions to generate one or more fragment ions
Data Source
AI summary
The invention relates to the detection of non-metabolized vitamin D. In a particular aspect, the invention relates to methods for detecting underivatized non-metabolized vitamin D by mass spectrometry.